{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:23:45Z","timestamp":1790346225971,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10072-025-08406-1","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T04:48:30Z","timestamp":1755492510000},"page":"4925-4941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuroglial biomarkers in autoimmune encephalitis: advances in diagnosis, prognosis, and pathophysiological insights"],"prefix":"10.1007","volume":"46","author":[{"given":"Maria S.","family":"Borioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia L.","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierludovico","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1890-5409","authenticated-orcid":false,"given":"Carlo","family":"Di Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Cerulli","family":"Irelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"8406_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"8406_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840\u2013851","journal-title":"N Engl J Med"},{"key":"8406_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1515\/cclm-2023-0518","volume":"62","author":"D Wilson","year":"2024","unstructured":"Wilson D, Chan D, Chang L et al (2024) Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clin Chem Lab Med (CCLM) 62:322\u2013331","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"8406_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.567587","author":"Z Tan","year":"2020","unstructured":"Tan Z, Jiang J, Tian F, Peng J, Yang Z, Li S, Long X (2020) Serum visinin-like protein 1 is a better biomarker than neuron-specific enolase for seizure-induced neuronal injury: a prospective and observational study. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.567587","journal-title":"Front Neurol"},{"key":"8406_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3940(01)01556-7","volume":"300","author":"SD S\u00fcssmuth","year":"2001","unstructured":"S\u00fcssmuth SD, Reiber H, Tumani H (2001) Tau protein in cerebrospinal fluid (CSF): a blood\u2013CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 300:95\u201398","journal-title":"Neurosci Lett"},{"issue":"9","key":"8406_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H et al (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology. JAMA Neurol 76:1035","journal-title":"JAMA Neurol"},{"key":"8406_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091361","author":"AM Jurga","year":"2021","unstructured":"Jurga AM, Paleczna M, Kadluczka J, Kuter KZ (2021) Beyond the GFAP-astrocyte protein markers in the brain. Biomolecules. https:\/\/doi.org\/10.3390\/biom11091361","journal-title":"Biomolecules"},{"key":"8406_CR8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/alz.12554","volume":"18","author":"A Padovani","year":"2022","unstructured":"Padovani A, Canale A, Schiavon L et al (2022) Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis. Alzheimers Dement 18:2167\u20132175","journal-title":"Alzheimers Dement"},{"key":"8406_CR9","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71","DOI":"10.1136\/bmj.n71"},{"key":"8406_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529","journal-title":"Ann Intern Med"},{"key":"8406_CR11","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s10072-024-07341-x","volume":"45","author":"Q Hao","year":"2024","unstructured":"Hao Q, Gong Z, Song Y, Wang Y, Meng W, Wu W, Li Y, Zhang Y (2024) Amyloid and tau as cerebrospinal fluid biomarkers in anti-N-methyl-D-aspartate receptor encephalitis. Neurol Sci 45:3399\u20133410","journal-title":"Neurol Sci"},{"key":"8406_CR12","doi-asserted-by":"publisher","unstructured":"Brenner J, Mariotto S, Bastiaansen AEM, et al (2023) Predictive value of serum neurofilament light chain levels in Anti-NMDA receptor encephalitis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000207221","DOI":"10.1212\/WNL.0000000000207221"},{"key":"8406_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/biomedicines10061262","volume":"10","author":"AG Vakrakou","year":"2022","unstructured":"Vakrakou AG, Tzartos JS, Strataki E, Boufidou F, Dimou E, Pyrgelis E-S, Constantinides VC, Paraskevas GP, Kapaki E (2022) Neuronal and neuroaxonal damage cerebrospinal fluid biomarkers in autoimmune encephalitis associated or not with the presence of tumor. Biomedicines 10:1262","journal-title":"Biomedicines"},{"key":"8406_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.689975","author":"R Kammeyer","year":"2022","unstructured":"Kammeyer R, Mizenko C, Sillau S, Richie A, Owens G, Nair KV, Alvarez E, Vollmer TL, Bennett JL, Piquet AL (2022) Evaluation of plasma neurofilament light chain levels as a biomarker of neuronal injury in the active and chronic phases of autoimmune neurologic disorders. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.689975","journal-title":"Front Neurol"},{"key":"8406_CR15","doi-asserted-by":"publisher","unstructured":"Guasp M, Mart\u00edn-Aguilar L, Sabater L et al (2022) Neurofilament light chain levels in Anti-NMDAR encephalitis and primary psychiatric psychosis.\u00a0Neurology.\u00a0https:\/\/doi.org\/10.1212\/WNL.0000000000200021","DOI":"10.1212\/WNL.0000000000200021"},{"key":"8406_CR16","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s10072-021-05838-3","volume":"43","author":"X Ma","year":"2022","unstructured":"Ma X, Lu Y, Peng F et al (2022) Serum NfL associated with anti-NMDA receptor encephalitis. Neurol Sci 43:3893\u20133899","journal-title":"Neurol Sci"},{"key":"8406_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719432","author":"MS Nissen","year":"2021","unstructured":"Nissen MS, Ryding M, Nilsson AC, Madsen JS, Olsen DA, Halekoh U, Lydolph M, Illes Z, Blaabjerg M (2021) CSF-neurofilament light chain levels in NMDAR and LGI1 encephalitis: a national cohort study. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.719432","journal-title":"Front Immunol"},{"key":"8406_CR18","doi-asserted-by":"publisher","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","volume":"96","author":"GS Day","year":"2021","unstructured":"Day GS, Yarbrough MY, K\u00f6rtvelyessy P et al (2021) Prospective quantification of CSF biomarkers in antibody-mediated encephalitis. Neurology 96:e2546\u2013e2557","journal-title":"Neurology"},{"key":"8406_CR19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11011-019-00452-x","volume":"34","author":"V Fominykh","year":"2019","unstructured":"Fominykh V, Brylev L, Gaskin V, Luzin R, Yakovlev A, Komoltsev I, Belousova I, Rosliakova A, Guekht A, Gulyaeva N (2019) Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis. Metab Brain Dis 34:1473\u20131485","journal-title":"Metab Brain Dis"},{"key":"8406_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00415-019-09306-z","volume":"266","author":"S Mariotto","year":"2019","unstructured":"Mariotto S, Gajofatto A, Zuliani L et al (2019) Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis. J Neurol 266:1643\u20131648","journal-title":"J Neurol"},{"key":"8406_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ene.12942","volume":"23","author":"R Constantinescu","year":"2016","unstructured":"Constantinescu R, Kr\u00fdsl D, Bergquist F et al (2016) Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis. Eur J Neurol 23:796\u2013806","journal-title":"Eur J Neurol"},{"key":"8406_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneuroim.2017.02.018","volume":"306","author":"R Constantinescu","year":"2017","unstructured":"Constantinescu R, Kr\u00fdsl D, Andr\u00e9n K et al (2017) Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies. J Neuroimmunol 306:25\u201330","journal-title":"J Neuroimmunol"},{"key":"8406_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jnc.15700","volume":"164","author":"X Chen","year":"2023","unstructured":"Chen X, Fang L, Peng F, Wang Y, Dai Z, Wang J, Shu Y, Qiu W (2023) Serum neurofilament light chain is associated with disturbed limbic-based functional connectivity in patients with <\u2009scp\u2009>\u2009anti\u2010NMDAR\u2009encephalitis. J Neurochem 164:210\u2013225","journal-title":"J Neurochem"},{"key":"8406_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578119","volume":"381","author":"J Li","year":"2023","unstructured":"Li J, Wang Y, Xia R, Zhao X, Li L, Wang S (2023) Elevated cerebrospinal fluid YKL-40 levels in patients with anti-gamma-aminobutyric- acid-B receptor encephalitis. J Neuroimmunol 381:578119","journal-title":"J Neuroimmunol"},{"key":"8406_CR25","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/ene.15469","volume":"29","author":"BK Chang","year":"2022","unstructured":"Chang BK, Day GS, Graff-Radford J et al (2022) Alzheimer\u2019s disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt\u2013Jakob disease and autoimmune encephalitis. Eur J Neurol 29:2905\u20132912","journal-title":"Eur J Neurol"},{"key":"8406_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/ene.14631","volume":"28","author":"S Macher","year":"2021","unstructured":"Macher S, Zrzavy T, H\u00f6ftberger R, Altmann P, Pataraia E, Zimprich F, Berger T, Rommer P (2021) Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N\u2010methyl\u2010D\u2010aspartate receptor encephalitis. Eur J Neurol 28:1401\u20131405","journal-title":"Eur J Neurol"},{"key":"8406_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1354","author":"J Li","year":"2019","unstructured":"Li J, Gu Y, An H, Zhou Z, Zheng D, Wang Z, Wen Z, Shen H, Wang Q, Wang H (2019) Cerebrospinal fluid light and heavy neurofilament level increased in anti- N \u2010methyl\u2010 <scp\u2009>\u2009d \u2010aspartate receptor encephalitis<\/scp\u2009>. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.1354","journal-title":"Brain Behav"},{"key":"8406_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3389\/fneur.2018.00668","volume":"9","author":"P K\u00f6rtvelyessy","year":"2018","unstructured":"K\u00f6rtvelyessy P, Pr\u00fcss H, Thurner L et al (2018) Biomarkers of neurodegeneration in autoimmune-mediated encephalitis. Front Neurol 9:668","journal-title":"Front Neurol"},{"key":"8406_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.647428","author":"RD Nass","year":"2021","unstructured":"Nass RD, Akg\u00fcn K, Dague KO, Elger CE, Reichmann H, Ziemssen T, Surges R (2021) CSF and serum biomarkers of cerebral damage in autoimmune epilepsy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.647428","journal-title":"Front Neurol"},{"key":"8406_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1439","author":"G Dorcet","year":"2023","unstructured":"Dorcet G, Benaiteau M, Pariente J et al (2023) Cerebrospinal fluid YKL-40 level evolution is associated with autoimmune encephalitis remission. Clin Transl Immunol. https:\/\/doi.org\/10.1002\/cti2.1439","journal-title":"Clin Transl Immunol"},{"key":"8406_CR31","doi-asserted-by":"publisher","unstructured":"Cheng Y, Chen S, Zhang Y et al (2024) Novel diagnostic and prognostic approach for rapidly progressive dementias: indicators based on amyloid\/tau\/neurodegeneration (ATN) framework.\u00a0CNS Neurosci Ther.\u00a0https:\/\/doi.org\/10.1111\/cns.14857","DOI":"10.1111\/cns.14857"},{"key":"8406_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00415-021-10642-2","volume":"269","author":"P Lardeux","year":"2022","unstructured":"Lardeux P, Fourier A, Peter E et al (2022) Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis. J Neurol 269:377\u2013388","journal-title":"J Neurol"},{"key":"8406_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200176","author":"K Eisenhut","year":"2024","unstructured":"Eisenhut K, Faber J, Engels D et al (2024) Early neuroaxonal damage in neurologic disorders associated with GAD65 antibodies. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200176","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8406_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/brain\/awac090","volume":"146","author":"T Gr\u00fcter","year":"2023","unstructured":"Gr\u00fcter T, M\u00f6llers FE, Tietz A et al (2023) Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain 146:600\u2013611","journal-title":"Brain"},{"key":"8406_CR35","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001039","author":"AEM Bastiaansen","year":"2021","unstructured":"Bastiaansen AEM, van Steenhoven RW, de Bruijn MAAM et al (2021) Autoimmune encephalitis resembling dementia syndromes. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001039","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8406_CR36","doi-asserted-by":"publisher","first-page":"104955","DOI":"10.1016\/j.ebiom.2023.104955","volume":"100","author":"S Bjursten","year":"2024","unstructured":"Bjursten S, Zhao Z, Al Remawi H et al (2024) Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation. EBioMedicine 100:104955","journal-title":"EBioMedicine"},{"key":"8406_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","volume":"80","author":"EP Flanagan","year":"2023","unstructured":"Flanagan EP, Geschwind MD, Lopez-Chiriboga AS et al (2023) Autoimmune encephalitis misdiagnosis in adults. JAMA Neurol 80:30","journal-title":"JAMA Neurol"},{"key":"8406_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1165153","author":"N Hansen","year":"2023","unstructured":"Hansen N, Juhl AL, Grenzer IM, Teegen B, Wiltfang J, Fitzner D (2023) Cerebrospinal fluid biomarkers in psychiatric autoimmune encephalitis: a retrospective cohort study. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2023.1165153","journal-title":"Front Psychiatry"},{"key":"8406_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.neurol.2024.08.006","volume":"180","author":"TJ Hartung","year":"2024","unstructured":"Hartung TJ, Bartels F, Kuchling J, Krohn S, Leidel J, Mantwill M, Wurdack K, Yogeshwar S, Scheel M, Finke C (2024) MRI findings in autoimmune encephalitis. Rev Neurol (Paris) 180:895\u2013907","journal-title":"Rev Neurol (Paris)"},{"key":"8406_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.0000000000012195","volume":"97","author":"MJ Titulaer","year":"2021","unstructured":"Titulaer MJ, Day GS (2021) Autoimmune encephalitis in first episode psychoses. Neurology 97:16\u201317","journal-title":"Neurology"},{"key":"8406_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18:1045\u20131057","journal-title":"Lancet Neurol"},{"key":"8406_CR42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","volume":"70","author":"MS Kayser","year":"2013","unstructured":"Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J (2013) Frequency and characteristics of isolated psychiatric episodes in Anti\u2013 N -Methyl- <scp\u2009>\u2009d -Aspartate receptor encephalitis<\/scp\u2009>. JAMA Neurol 70:1133","journal-title":"JAMA Neurol"},{"key":"8406_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","volume":"270","author":"D Endres","year":"2020","unstructured":"Endres D, Leypoldt F, Bechter K et al (2020) Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci 270:803\u2013818","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8406_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jpsychires.2022.05.008","volume":"151","author":"M Funayama","year":"2022","unstructured":"Funayama M, Koreki A, Takata T et al (2022) Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. J Psychiatr Res 151:419\u2013426","journal-title":"J Psychiatr Res"},{"key":"8406_CR45","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S et al (2021) Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92:757\u2013768","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8406_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12060773","author":"Y Gao","year":"2022","unstructured":"Gao Y, Pan J, Shen D, Peng L, Mao Z, Wang C, Meng H, Zhou Q, Chen S (2022) Immune checkpoint inhibitor associated autoimmune encephalitis, rare and novel topic of neuroimmunology: a case report and review of the literature. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12060773","journal-title":"Brain Sci"},{"key":"8406_CR47","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider BJ, Naidoo J, Santomasso BD et al (2021) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol 39:4073\u20134126","journal-title":"J Clin Oncol"},{"key":"8406_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267","journal-title":"Signal Transduct Target Ther"},{"key":"8406_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358\u2013372","journal-title":"Nat Rev Neurosci"},{"key":"8406_CR50","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","volume":"14","author":"RD Moir","year":"2018","unstructured":"Moir RD, Lathe R, Tanzi RE (2018) The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimers Dement 14:1602\u20131614","journal-title":"Alzheimers Dement"},{"key":"8406_CR51","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/1352458512460603","volume":"19","author":"K Augutis","year":"2013","unstructured":"Augutis K, Axelsson M, Portelius E et al (2013) Cerebrospinal fluid biomarkers of \u03b2-amyloid metabolism in multiple sclerosis. Mult Scler J 19:543\u2013552","journal-title":"Mult Scler J"},{"key":"8406_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1460-9568.2010.07349.x","volume":"32","author":"EH Moscato","year":"2010","unstructured":"Moscato EH, Jain A, Peng X, Hughes EG, Dalmau J, Balice-Gordon RJ (2010) Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 32:298\u2013309","journal-title":"Eur J Neurosci"},{"key":"8406_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00727","author":"J Chen","year":"2018","unstructured":"Chen J, Ding Y, Zheng D, Wang Z, Pan S, Ji T, Shen H-Y, Wang H (2018) Elevation of YKL-40 in the CSF of anti-NMDAR encephalitis patients is associated with poor prognosis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.00727","journal-title":"Front Neurol"},{"key":"8406_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14291","author":"M Fernandez Suarez","year":"2016","unstructured":"Fernandez Suarez M, Surace EI, Riudavets M, Nogues M, Vazquez S, Sevlever G, Allegri RF (2016) Alzheimer\u2019s disease biomarker profile in cerebrospinal fluid of individuals with immune-mediated encephalitis. J Am Geriatr Soc. https:\/\/doi.org\/10.1111\/jgs.14291","journal-title":"J Am Geriatr Soc"},{"key":"8406_CR55","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awab153","volume":"144","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S, Hedou JJ, Ambati A et al (2021) Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis. Brain 144:2709\u20132721","journal-title":"Brain"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08406-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T03:12:48Z","timestamp":1759288368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08406-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8406"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08406-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required. The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"CDB reports personal fees from UCB Pharma, Eisai, GW Pharmaceuticals, Angelini Pharma, Lusofarmaco, and Ecupharma. ECI reports speaking honoraria from Lusofarmaco and travel support from UCB Pharma and Angelini Pharma. Other authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}